Vascular Access Devices Market
Report ID: SQMIG35A4002
Report ID: SQMIG35A4002
[email protected]
USA +1 351-333-4748
Report ID:
SQMIG35A4002 |
Region:
Global |
Published Date: June, 2026
Pages:
157
|Tables:
145
|Figures:
78
Global Vascular Access Devices Market size was valued at USD 6.33 Billion in 2024 and is poised to grow from USD 6.71 Billion in 2025 to USD 10.64 Billion by 2033, growing at a CAGR of 5.94% during the forecast period (2026-2033).
The vascular access devices market encompasses peripheral intravenous catheters, peripherally inserted central catheters, central venous catheters and implantable ports used to deliver fluids, medications and dialysis, and its primary driver is the rising prevalence of chronic diseases and expanded outpatient infusion therapies. This market matters because reliable vascular access reduces inpatient stays, prevents complications and enables complex treatments such as oncology regimens and long-term parenteral nutrition. Over time the market has evolved from basic steel cannulas to sophisticated coated, safety-engineered and ultrasound-compatible devices, and examples include growing PICC use for home infusion and antimicrobial-impregnated catheters to curb bloodstream infections effectively.
Building on that evolution, the principal growth factor in the global vascular access devices market is technological innovation combined with shifting care settings, because safer, smarter devices enable wider use across hospitals, outpatient infusion centers and home care while payers reward reduced complications. For example, adoption of ultrasound-guided insertion and antimicrobial-coated catheters has decreased insertion failures and bloodstream infections, which in turn lowers length of stay and drives procurement budgets toward premium devices. Consequently manufacturers invest in safety mechanisms and monitoring, creating opportunities in emerging markets where expanding dialysis and oncology services replicate developed market demand with scalable, affordable solutions.
How is AI improving clinical outcomes in the vascular access devices market?
AI is improving clinical outcomes in the vascular access devices market, through improved imaging guidance, procedural planning and clinical decision support. Key features include AI powered ultrasound assistance for improved visualization of vessels and targeting of the needle, predictive analytics to help guide device selection and timing of access, and automated image analysis to assist with navigation during angiography. The environment is primed for AI to support point of care tools and catheter workflows that allow clinicians to perform less invasive procedures with fewer complications. The market dynamics favor technologies that can reduce procedure time and improve first attempt success and hospitals are adopting devices that provide more consistent results.
GE HealthCare in April 2026 Launched upgraded Venue point of care ultrasound systems with AI guided captioning to improve image quality and provide real time scan coaching. This helps the market grow by improving efficiency and standardizing outcomes, and helps clinicians find vessels more quickly and perform safer insertions.
Market snapshot - (2026-2033)
Global Market Size
USD 6.33 Billion
Largest Segment
Peripheral Vascular Access Devices
Fastest Growth
Central Vascular Access Devices
Growth Rate
5.94% CAGR
To get more insights on this market click here to Request a Free Sample Report
Global vascular access devices market is segmented by device type, application area, material focus, end-user, sales channel and region. Based on device type, the market is segmented into Central Vascular Access Devices, Peripheral Vascular Access Devices and Others. Based on application area, the market is segmented into Medication Administration, Fluid and Nutrition Administration, Diagnostics and Testing and Others. Based on material focus, the market is segmented into Polyurethane, Silicone and Others. Based on end-user, the market is segmented into Hospitals, Ambulatory Surgery Centers and Others. Based on sales channel, the market is segmented into Direct Institutional Sales, Medical Device Wholesalers and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
The central vascular access devices segment held the largest share of the vascular access devices market in 2021, based on type. This is due to the fact that these devices offer stable, long-term intravascular access, which is perfect for complex therapies and repetitive administrations. They are designed for more permanent placement, higher flow rates and are compatible with advanced infusion protocols, thereby reducing procedural burden and improving therapy continuity. The devices are purchased and built on safety features, securement and infection control preferred by clinicians and institutional protocols for oncology, critical care and parenteral nutrition.
However, the fastest growing segment of the market is being shown to be Peripheral Vascular Access Devices due to the increasing demand for short term IV therapy, outpatient infusion and easier bedside placement. Innovations in catheter materials, needle-free connectors and portable infusion systems are driving adoption in ambulatory and home care settings, simplifying procedures and enabling cost-effective care pathways.
The polyurethane segment holds the largest share, owing to its combination of tensile strength, flexibility and surface smoothness, allowing thinner wall, high flow catheters to withstand prolonged indwelling times while maintaining lumen integrity. These material benefits reduce mechanical failure, and allow for the addition of advanced coatings, which reduce complication risks and meet clinician preference for durable high performance lines. Manufacturers are adopting polyurethane due to its scalability and ability to meet evolving infection control and hemodynamic requirements.
However, there is increasing demand for soft, long term indwelling catheters in sensitive populations and silicone is demonstrating the strongest growth momentum with its superior biocompatibility and low thrombogenic profile. Advances in silicone processing, surface modifications and device designs are creating new applications, prompting clinicians to adopt silicone options and driving R&D and market opportunities.
To get detailed segments analysis, Request a Free Sample Report
North America is the leading region due to the availability of advanced clinical infrastructure, industry presence and wide clinical adoption of minimally invasive techniques. A mature healthcare ecosystem allows for the rapid integration of new devices through collaborative pathways between hospitals, academic centers and industry. The region’s reimbursement models and procurement practices are conducive to investment in high quality vascular access solutions and clear and strong regulatory pathways enable efficient product development and market access. The region is also home to headquarters, distribution networks and innovation centers of major manufacturers, supporting supply chain resilience and aftersales support. Deep clinician expertise and specialized training programs help disseminate best practices and drive the adoption of newer technologies in hospital and outpatient settings, maintaining market leadership.
The United States Vascular Access Devices Market is driven by integrated hospital systems, dedicated vascular teams and a rich network of clinical research sites that help in validation and adoption of technologies. The market is characterized by a competitive supplier base, strong distributor channels and a focus on procedural efficiency and patient safety. Rapid clinical uptake is driven by clinician preference for evidence based devices, availability of advanced training, procurement across large health systems, and standardization and scale.
The Canadian Vascular Access Devices Market is supported by a public health system that emphasizes safe and cost-effective vascular care and standardized clinical protocols. Provincial health authorities and regional procurement collaboratives shape the pathways to device selection and adoption. The assessment of new technologies is focused on clinical networks and academic hospitals. Collaborations with manufacturers are linked to service, training and long term clinical outcomes. To support these different adoption patterns in rural and urban care settings, manufacturers develop customized support models.
Europe is seeing rapid expansion, driven by harmonised regulatory initiatives, a growing focus on outpatient and day care procedures, and increasing cross border collaboration between healthcare providers. A strong medical device industry in various countries fosters a thriving innovation ecosystem and first-rate clinical networks and centers of excellence are leaders in evidence creation and sharing of best practices. Health technology assessment processes and hospital procurement frameworks are increasingly focused on value and patient experience, which is good news for advanced vascular access solutions that reduce complications and length of stay. The market expansion is also facilitated by the strategic collaborations between local distributors and global manufacturers. Such partnerships help companies to reach a larger market and provide services adapted to the various care pathways in the region.
Devices for Vascular Access Germany has a strong hospital infrastructure, advanced interventional capabilities and high clinician expertise in vascular procedures. Regional centers of excellence and close cooperation between manufacturers and clinical research institutions enable rigorous evaluation of devices and their early integration into clinical practice. The procurement process is very quality and clinical outcomes driven, and that drives the adoption of sophisticated solutions for vascular access, which is supportive of the goals of efficiency and patient safety.
An active focus on improving patient pathways, increased outpatient procedure volume and national initiatives for reducing hospital stays are driving the United Kingdom Vascular Access Devices Market. Centralized purchasing systems and clinical leadership in vascular access help to scale up innovation in devices. Health systems often support manufacturers through training programmes and demonstration projects to facilitate evidence based uptake and to ensure product value propositions are aligned with national health priorities.
Vascular Access Device The French market is moving to more of a focus on device performance, patient comfort and procedural efficiency. Academic hospitals and regional health networks are important testing grounds for new technologies. Clinical evidence and cost-effectiveness considerations guide the decisions on reimbursement and procurement. With clinical support that is targeted and partnerships with local distributors, it is easy to access a wide range of hospital settings.
Asia Pacific is taking a larger market share through strategic investments in healthcare infrastructure, the expansion of private and public hospital networks and a boost in local manufacturing capabilities. There is a growing focus on minimally invasive care models and training programs in the region that enhance the procedural skills of clinicians. Some markets are moving towards harmonization of their regulatory environments with international standards, which allows for a faster uptake of global innovations, and also for the development of local products. Multinational manufacturers are forming strategic partnerships with regional distributors to improve their market penetration and service. Increasing collaborations between academic centers and industry are also generating locally relevant clinical evidence that is helping to drive wider clinical acceptance and adoption of customized devices in diverse settings of care.
The Japanese market for Vascular Access Devices reflects a mature clinical environment with strong emphasis on device quality, reliability and incremental innovation. Hospital systems care about patient safety and accuracy of procedures so the demand for advanced vascular access solutions. They partner with academic institutions so that the clinical testing can be done rigorously. Distributor networks offer extensive training and aftersales support to maintain high standards of care.
The South Korea Vascular Access Devices Market is driven by a robust medical device industry, rapid clinical adoption of new technologies and hospitals actively investing in interventional capabilities. Manufacturers work with clinical centers to generate evidence and to refine the features of the product to local practice. The competitive environment places a premium on procedural efficiency and integration into outpatient and tertiary care pathways, which benefits innovation and service differentiation.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Rising Chronic Disease Prevalence
Advances In Device Design
High Cost Of Specialized Devices
Regulatory Complexity And Variability
Request Free Customization of this report to help us to meet your business objectives.
The competitive landscape in the global vascular access devices market is being defined by consolidation, technology acquisition and commercial alliances as players vie for differentiation through integrated monitoring and sensor-enabled platforms. Recent M&A and licensing moves, such as the AngioDynamics acquisition of Eximo Medical and commercialization partnerships between device innovators and infusion system leaders, are evidence of this trend. These strategies accelerate the adoption of digital sensing and wearable monitoring as a key competitive driver.
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
As per SkyQuest analysis, the global vascular access devices market is poised for steady growth driven primarily by technological innovation and the shift toward outpatient and home infusion therapies, with a second major driver being rising chronic disease prevalence that increases long term access needs. Adoption of ultrasound guidance, antimicrobial coatings and sensor enabled platforms is expanding use across care settings, yet high costs of specialized devices remain a notable restraint limiting uptake in resource constrained markets. North America continues to dominate due to advanced clinical infrastructure and reimbursement support, while the central vascular access devices segment leads given its role in long duration, complex therapies and institutional preference.
| Report Metric | Details |
|---|---|
| Market size value in 2024 | USD 6.33 Billion |
| Market size value in 2033 | USD 10.64 Billion |
| Growth Rate | 5.94% |
| Base year | 2024 |
| Forecast period | (2026-2033) |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Table Of Content
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
Methodology
For the Vascular Access Devices Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Vascular Access Devices Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Vascular Access Devices Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Vascular Access Devices Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
REQUEST FOR SAMPLE
REQUEST FREE CUSTOMIZATION
Global Vascular Access Devices Market size was valued at USD 6.33 Billion in 2024 and is poised to grow from USD 6.71 Billion in 2025 to USD 10.64 Billion by 2033, growing at a CAGR of 5.94% during the forecast period (2026-2033).
Competitive dynamics in the global vascular access devices market center on consolidation, technology acquisition and commercial alliances as firms seek differentiation through integrated monitoring and sensor enabled platforms. Recent M&A and licensing moves illustrate this trend, for example AngioDynamics acquisition of Eximo Medical and commercialization partnerships between device innovators and infusion system leaders. These strategies accelerate adoption of digital sensing and wearable monitoring as a primary competitive driver. 'Becton Dickinson (BD)', 'Teleflex', 'ICU Medical', 'Nipro Corporation', 'Vygon', 'Smiths Medical', 'C.R. Bard', 'AngioDynamics', 'Argon Medical', 'Medtronic', 'Fresenius', 'B. Braun', 'Terumo', 'Cook Medical', 'Delta Med', 'Navilyst Medical', 'PFM Medical', 'Amecath', 'Medcomp', 'Romsons'
Growing prevalence of chronic conditions such as renal failure and cancer has elevated long term vascular access requirements, prompting sustained demand for a range of devices. Clinicians increasingly rely on durable and reliable access solutions to support repeated therapeutic interventions and long term infusion therapies, which in turn motivates manufacturers to expand product portfolios and distribution. This persistent clinical need underpins procurement priorities within healthcare systems and encourages investment in device availability, training, and support services, thereby reinforcing market expansion through consistent utilization.
Minimally Invasive Procedures Adoption: The growing preference for minimally invasive vascular access is driving demand for devices that simplify bedside procedures, reduce patient discomfort, and lower complication risk. Clinicians favor ergonomically designed, single-use systems with atraumatic tips and integrated safety features that streamline insertion and securement. Manufacturers prioritize ease of use, compatibility with imaging guidance, and training to accelerate clinical adoption. Hospitals and providers seek products that align with procedural standardization and workflow efficiency, prompting collaborative design that emphasizes reliability, infection prevention, and improved recovery.
Why does North America Dominate the Global Vascular Access Devices Market? |@12
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Feedback From Our Clients
USA (+1) 351-333-4748
